David M. Garner
Research Subjects
Research Interests
David M. Garner has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Dennis L. Jackson
Department of Psychology, University of Windsor, Windsor, ON N9B 3P4, Canada
2 shared publications - Jeffrey B. Brookings
Psychology Department, Wittenberg University, Springfield, USA
2 shared publications Christopher D. Keiper
River Centre Foundation, 5445 Main Street, Sylvania, OH, 43560, USA
1 shared publicationLisa Parker
University of Toledo Medical Center, 3000 Arlington Avenue, Toledo, OH, 43614, USA
1 shared publicationMichael L. Anderson
River Centre Clinic, 5465 Main Street, Sylvania, OH, 43560, USA
1 shared publicationRachel Whynott
University of Toledo Medical Center, 3000 Arlington Avenue, Toledo, OH, 43614, USA
1 shared publication
Latest Publications
- 16 September 2020
- Published by Springer Nature in Journal of Psychopathology and Behavioral Assessment
- Vol. 43 (1) , 205
Correction to: A Bifactor and Item Response Theory Analysis of the Eating Disorder Inventory-3
- 16 September 2020
- Published by Springer Nature in Journal of Psychopathology and Behavioral Assessment
- Vol. 43 (1) , 205
Correction to: A Bifactor and Item Response Theory Analysis of the Eating Disorder Inventory-3
- 28 July 2020
- Published by Springer Nature in Journal of Psychopathology and Behavioral Assessment
- Vol. 43 (1) , 191-204
A Bifactor and Item Response Theory Analysis of the Eating Disorder Inventory-3
- 28 July 2020
- Published by Springer Nature in Journal of Psychopathology and Behavioral Assessment
- Vol. 43 (1) , 191-204
A Bifactor and Item Response Theory Analysis of the Eating Disorder Inventory-3
- Open Access
- 30 June 2016
- Published by ClinMed International Library in International Journal of Physiatry
- Vol. 2 (1)
The Disconnect between Treatment Outcome Data and Reimbursement for the Treatment of Anorexia Nervosa
A major problem plaguing the discussion of insurance reimbursement for the treatment of anorexia nervosa is the apparent gap between research on variables associated with outcome and the formulas used for reimbursement.
- 30 June 2016
- Published by ClinMed International Library in International Journal of Physiatry
- Vol. 2 (1)
Open AccessThe Disconnect between Treatment Outcome Data and Reimbursement for the Treatment of Anorexia Nervosa
A major problem plaguing the discussion of insurance reimbursement for the treatment of anorexia nervosa is the apparent gap between research on variables associated with outcome and the formulas used for reimbursement.
- 1 February 2016
- Published by Springer Nature in Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
- Vol. 21 (3) , 395-402
Psychotropic medications in adult and adolescent eating disorders: clinical practice versus evidence-based recommendations
Aim The current study examined the frequency of psychotropic prescriptions in a clinical sample of eating disorder (ED) patients confirming earlier research indicating their use is very common but inconsistent with evidence-based recommendations. Methods The sample consisted of 501 ED patients admitted to an adult partial hospitalization or adolescent residential program. Patients were divided into two diagnostic groups: anorexia nervosa (AN = 287) and bulimia nervosa (BN = 214), as well as two age groups: adults (age ≥18; N = 318) and adolescents (age N = 183). Results Forty-one different psychotropic medications (891 prescriptions in all) were prescribed for 429 patients. Overall, 85.6 % of the total sample reported using one or more psychotropic medications. Of 429 patients using any medications, 46.9 % were on two or more, 25.3 % on three or more, and 11.0 % four or more. Antidepressants were most commonly prescribed (89.5 % of those on medication) with no significant differences in usage patterns based on diagnosis. However, there was greater medication use among adults (89.6 %) compared to adolescents (78.7 %). Results indicate psychotropic medication prescription is more widespread in a clinical sample than in an earlier report screening for osteoporosis in AN women. Discussion Treatment recommendations suggest medication should not be the primary treatment for EDs and empirical evidence demonstrates their ineffectiveness in AN. Nevertheless, there were no differences in frequency found between diagnostic groups, confirming little relationship between evidence-based recommendations and actual clinical use for those referred to a specialized ED treatment facility. This study adds new evidence regarding age-based comparisons of psychotropic prescription frequency in clinical EDs and comparison between AN and BN which has not been examined in earlier studies.
- 1 February 2016
- Published by Springer Nature in Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
- Vol. 21 (3) , 395-402
Psychotropic medications in adult and adolescent eating disorders: clinical practice versus evidence-based recommendations
Aim The current study examined the frequency of psychotropic prescriptions in a clinical sample of eating disorder (ED) patients confirming earlier research indicating their use is very common but inconsistent with evidence-based recommendations. Methods The sample consisted of 501 ED patients admitted to an adult partial hospitalization or adolescent residential program. Patients were divided into two diagnostic groups: anorexia nervosa (AN = 287) and bulimia nervosa (BN = 214), as well as two age groups: adults (age ≥18; N = 318) and adolescents (age N = 183). Results Forty-one different psychotropic medications (891 prescriptions in all) were prescribed for 429 patients. Overall, 85.6 % of the total sample reported using one or more psychotropic medications. Of 429 patients using any medications, 46.9 % were on two or more, 25.3 % on three or more, and 11.0 % four or more. Antidepressants were most commonly prescribed (89.5 % of those on medication) with no significant differences in usage patterns based on diagnosis. However, there was greater medication use among adults (89.6 %) compared to adolescents (78.7 %). Results indicate psychotropic medication prescription is more widespread in a clinical sample than in an earlier report screening for osteoporosis in AN women. Discussion Treatment recommendations suggest medication should not be the primary treatment for EDs and empirical evidence demonstrates their ineffectiveness in AN. Nevertheless, there were no differences in frequency found between diagnostic groups, confirming little relationship between evidence-based recommendations and actual clinical use for those referred to a specialized ED treatment facility. This study adds new evidence regarding age-based comparisons of psychotropic prescription frequency in clinical EDs and comparison between AN and BN which has not been examined in earlier studies.